InvestorsHub Logo
Post# of 251798
Next 10
Followers 10
Posts 363
Boards Moderated 0
Alias Born 02/04/2014

Re: None

Wednesday, 05/27/2015 9:27:41 AM

Wednesday, May 27, 2015 9:27:41 AM

Post# of 251798
Zogenix Announces New Efficacy Data From a Long-Term Study of Low-Dose Fenfluramine for Treatment of Dravet Syndrome. ZGNX

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.